Dermatology: 844-562-3376 | Gastroenterology: 785-354-8518 | Plastic Surgery: 785-271-2297
Kansas Medical Clinic, PA

Ulcerative Colitis

The present study (3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and endoscopy.

KMC Dermatology

Topeka, Lawrence, Emporia, Manhattan, Kansas City, Shawnee, Leawood, Olathe

KMC Gastroenterology

785-354-8518
2200 SW 6th Ave.
Topeka, KS 66606

Disclaimer

All information provided herein is for educational purposes only. If you have a medical condition, please consult a physician to get a proper diagnosis and treatment plan.

© Copyright 2018 - Kansas Medical Clinic, PA